THU0487 Real-Life Treatment With Canakinumab in Systemic Juvenile Idiopathic Arthritis – First Experience From the Biker Registry

doi 10.1136/annrheumdis-2017-eular.1745
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ Publishing Group Ltd and European League Against Rheumatism

Related search

Systemic Juvenile Idiopathic Arthritis in the Republic of Bashkortostan

Pediatric Rheumatology
ImmunologyPediatricsRheumatologyAllergyPerinatologyChild Health
2011English

Experience of Treatment of the Twins Sick With Juvenile Idiopathic Arthritis by Abatacept

Voprosy Sovremennoi Pediatrii - Current Pediatrics
Child HealthPediatricsPerinatology
2014English

Whole Exome Sequencing in Systemic Juvenile Idiopathic Arthritis

Pediatric Rheumatology
ImmunologyPediatricsRheumatologyAllergyPerinatologyChild Health
2015English

Epidemiology and Biologic Treatment Patterns of Systemic Juvenile Idiopathic Arthritis in Ontario

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

MEFV Mutations in Iranian Children With Systemic Onset Juvenile Idiopathic Arthritis

Pediatric Rheumatology
ImmunologyPediatricsRheumatologyAllergyPerinatologyChild Health
2014English

Myositis in the Course of the Systemic Form Juvenile Idiopathic Arthritis

Reumatologia
RheumatologyAllergyImmunology
2014English

Macrophage Activation Syndrome in Patients With Systemic Juvenile Idiopathic Arthritis Treated With Tocilizumab

Pediatric Rheumatology
ImmunologyPediatricsRheumatologyAllergyPerinatologyChild Health
2014English

PReS-FINAL-1005: Hypertransaminasemia in Systemic Juvenile Idiopathic Arthritis During Anti-Interleukin 1 Treatment

Pediatric Rheumatology
ImmunologyPediatricsRheumatologyAllergyPerinatologyChild Health
2013English

Juvenile Idiopathic Arthritis

The Lancet
Medicine
2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy